CSC
RXST icon

Caldwell Sutter Capital’s RxSight RXST Stock Holding History

Caldwell Sutter Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$2.08K – 897
2025
Q4 		$2.08K Hold
200
– – ﹤0.01% 742
2025
Q3 		$1.8K Hold
200
– – ﹤0.01% 750
2025
Q2 		$2.6K Hold
200
– – ﹤0.01% 689
2025
Q1 		$5.05K Sell
200
-20
-9% -$594 ﹤0.01% 623
2024
Q4 		$7.56K Hold
220
– – ﹤0.01% 584
2024
Q3 		$10.9K Hold
220
– – 0.01% 548
2024
Q2 		$13.2K Hold
220
– – 0.01% 526
2024
Q1 		$11.3K Buy
220
+20
+10% +$982 0.01% 531
2023
Q4 		$8.06K Buy
+200
New +$5.87K ﹤0.01% 568

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Caldwell Sutter Capital's RXST Position: Q1 2026 in Review

Caldwell Sutter Capital sold out of RxSight (RXST) in Q1 2026, closing a stake of 200 shares — an estimated $2.08K sold.

Caldwell Sutter Capital first reported a position in RXST in Q4 2023 and held it in 9 quarters. The position peaked at $13.2K in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Caldwell Sutter Capital reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Caldwell Sutter Capital sold 200 RxSight shares in Q1 2026, an estimated $2.08K.
  • Caldwell Sutter Capital first reported a position in RxSight in Q4 2023 and held it in 9 quarters.
  • Caldwell Sutter Capital's RxSight position peaked at $13.2K in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.